02Mar 2020

THE RELATIONSHIP BETWEEN SERUM RHOA AND MIR-133B IN ACUTE ISCHEMIC STROKE

  • Yongpeng Yu Innovation Studio and Department of Neurology, the Affiliated Weihai Central Hospital of Qingdao University and Weifang Medical College, Weihai, Shandong, 264400.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Objective: The present study investigates the expressions of miR-133b and RhoA in acute ischemic stroke (AIS) patients. Methods: In the present study, serum samples from AIS patients and healthy controls were collected to determine the regulatory miRNAs and RhoA involved in AIS.The expression levels of miR-133b in serum were detected by real-time quantitative PCR, and the expression levels of RhoA in blood were detected by ELISA. The correlation between the levels of miR-133b and RhoA was analyzed. Results: The results indicate that the RhoA level in the AIS patients is very high compared with that in controls. The level of miR-133b showed the opposite change with that of RhoA.The association between the National Institutes of Health stroke scale (NIHSS) scores with RhoA and miR-133b-related RhoA serum levels was calculated using Pearson?s/Spearman?s correlation coefficient. The findings revealed a positive correlation between NIHSS scores and RhoA level, whereas a negative correlation was observed between NIHSS scores and miR-133b. In addition, the relationship between serum RhoA and miR-133b was negative in AIS patients. Conclusion: Serum miR-133b and the miR-133b-regulatory RhoA may serve as molecular markers for AIS.

  1. Pierot L, Jayaraman MV, Szikora I, Hirsch JA, Baxter B, Miyachi S, et al. Standards of practice in acute ischemic stroke intervention: international recommendations. J Neurointerv Surg. 2018;10(11):1121-1126.
  2. Gong P, Li R, Jia HY, Ma Z, Li XY, Dai XR, et al. Anfibatide Preserves Blood-Brain Barrier Integrity by Inhibiting TLR4/RhoA/ROCK Pathway After Cerebral Ischemia/Reperfusion Injury in Rat. J Mol Neurosci. 2020;70(1):71-83.
  3. Chen J, Sun L, Ding GB, Chen L, Jiang L, Wang J, et al. Oxygen-Glucose Deprivation/Reoxygenation Induces Human Brain Microvascular Endothelial Cell Hyperpermeability Via VE-Cadherin Internalization: Roles of RhoA/ROCK2. J Mol Neurosci. 2019;69(1):49-59.
  4. Lu D, Ho ES, Mai H, Zang J, Liu Y, Li Y, et al. Identification of Blood Circular RNAs as Potential Biomarkers for Acute Ischemic Stroke. Front Neurosci. 2020;14:81.
  5. Sheikhbahaei S, Manizheh D, Mohammad S, Hasan TM, Saman N, Laleh R, et al. Can MiR-503 be used as a marker in diabetic patients with ischemic stroke? BMC Endocr Disord. 2019;19(1):42.
  6. ?akmak HA, Demir M. MicroRNA and Cardiovascular Diseases. Balkan Med J. 2020;37(2):60-71.
  7. Li SH, Chen L, Pang XM, Su SY, Zhou X, Chen CY, et al. Decreased miR-146a expression in acute ischemic stroke directly targets the Fbxl10 mRNA and is involved in modulating apoptosis. Neurochem Int. 2017;107:156-67.
  8. Kumar D, Narang R, Sreenivas V, Rastogi V, Bhatia J, Saluja D, et al. Circulatory miR-133b and miR-21 as Novel Biomarkers in Early Prediction and Diagnosis of Coronary Artery Disease. Genes (Basel). 2020;11(2).
  9. Chen YS, Hung TW, Su SC, Lin CL, Yang SF, Lee CC, et al. MTA2 as a Potential Biomarker and Its Involvement in Metastatic Progression of Human Renal Cancer by miR-133b Targeting MMP-9. Cancers (Basel). 2019;11(12).
  10. Lv L, Li Q, Chen S, Zhang X, Tao X, Tang X, et al. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L. Exp Cell Res. 2019;385(1):111597.
  11. Wang S, Huang M, Wang Z, Wang W, Zhang Z, Qu S, et al. MicroRNA‑133b targets TGFβ receptor I to inhibit TGF‑β‑induced epithelial‑to‑mesenchymal transition and metastasis by suppressing the TGF‑β/SMAD pathway in breast cancer. Int J Oncol. 2019;55(5):1097-1109.
  12. Yu H, Xu L, Liu Z, Guo B, Han Z, Xin H. Circ_MDM2_000139, Circ_ATF2_001418, Circ_CDC25C_002079, and Circ_BIRC6_001271 Are Involved in the Functions of XAV939 in Non-Small Cell Lung Cancer. Can Respir J. 2019;2019:9107806.
  13. Ohta S, Harigai M, Tanaka M, Kawaguchi Y, Sugiura T, Takagi K, et al. Tumor necrosis factor-alpha (TNF-alpha) converting enzyme contributes to production of TNF-alpha in synovial tissues from patients with rheumatoid arthritis. J Rheumatol. 2001;28(8):1756-63.
  14. Xin H, Li Y, Buller B, Katakowski M, Zhang Y, Wang X, et al. Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells. 2012;30(7):1556-64.
  15. Park JC, Baik SH, Han SH, Cho HJ, Choi H, Kim HJ, et al. Annexin A1 restores Aβ1-42-induced blood-brain barrier disruption through the inhibition of RhoA-ROCK signaling pathway. Aging Cell. 2017;16(1):149-161.
  16. Zhai L, Liu M, Wang T, Zhang H, Li S, Guo Y. Picroside II protects the blood-brain barrier by inhibiting the oxidative signaling pathway in cerebral ischemia-reperfusion injury. PLoS One. 2017;12(4):e0174414.
  17. Sun H, Zhong D, Wang C, Sun Y, Zhao J, Li G. MiR-298 Exacerbates Ischemia/Reperfusion Injury Following Ischemic Stroke by Targeting Act1. Cell Physiol Biochem. 2018;48(2):528-539.
  18. Wang LQ, Wang CL, Xu LN, Hua DF. The expression research of miR-210 in the elderly patients with COPD combined with ischemic stroke. Eur Rev Med Pharmacol Sci. 2016;20(22):4756-4760.
  19. Tiedt S, Prestel M, Malik R, Schieferdecker N, Duering M, Kautzky V, et al. RNA-Seq Identifies Circulating miR-125a-5p, miR-125b-5p, and miR-143-3p as Potential Biomarkers for Acute Ischemic Stroke. Circ Res. 2017;121(8):970-980.
  20. Xin H, Li Y, Liu Z, Wang X, Shang X, Cui Y, et al. MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells. 2013;31(12):2737-46.
  21. Huang B, Jiang XC, Zhang TY, Hu YL, Tabata Y, Chen Z, et al. Peptide modified mesenchymal stem cells as targeting delivery system transfected with miR-133b for the treatment of cerebral ischemia. Int J Pharm. 2017;531(1):90-100.

[Yong-Peng Yu, Ya-Li Zheng, Ting-Hong Yu, Jia-He Bai and Ting-Ting Jiang (2020); THE RELATIONSHIP BETWEEN SERUM RHOA AND MIR-133B IN ACUTE ISCHEMIC STROKE Int. J. of Adv. Res. 8 (Mar). 358-363] (ISSN 2320-5407). www.journalijar.com

Yong peng Yu
Yongpeng Yu Innovation Studio and Department of Neurology, the affiliated Weihai Central Hospital of Qingdao University and Weifang Medical College,

DOI:

Article DOI: 10.21474/IJAR01/10635      
DOI URL: https://dx.doi.org/10.21474/IJAR01/10635

Download Full Paper

Download PDF No. of Downloads: 12 | No. of Views: 53